questionsmedicales.fr
Phénomènes microbiologiques
Phénomènes physiologiques viraux
Réplication virale
Activation virale
Activation virale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Diagnostic
Infections virales
Tests de diagnostic
Virus
Symptômes
Infections virales
Biopsie
Infections virales
Symptômes
5
Symptômes
Infections virales
Complications
Infections virales
Symptômes
Maladies infectieuses
Prévention
5
Hygiène
Infections virales
Masques
Prévention des maladies
Voyages
Infections virales
Comportements à risque
Infections virales
Traitements
5
Traitement antiviral
Infections virales
Antibiotiques
Infections virales
Vaccins
Prévention des maladies
Complications
5
Complications
Infections virales
Maladies chroniques
Infections virales
Complications
État de santé
Gestion des complications
Infections virales
Facteurs de risque
5
Facteurs de risque
Infections virales
Maladies chroniques
Infections virales
Mode de vie
Infections virales
Stress
Infections virales
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Activation virale : Questions médicales les plus fréquentes",
"headline": "Activation virale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Activation virale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-12",
"dateModified": "2025-03-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Activation virale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Réplication virale",
"url": "https://questionsmedicales.fr/mesh/D014779",
"about": {
"@type": "MedicalCondition",
"name": "Réplication virale",
"code": {
"@type": "MedicalCode",
"code": "D014779",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G06.920.925"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Activation virale",
"alternateName": "Virus Activation",
"code": {
"@type": "MedicalCode",
"code": "D014775",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Duncan R Smith",
"url": "https://questionsmedicales.fr/author/Duncan%20R%20Smith",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand."
}
},
{
"@type": "Person",
"name": "Atitaya Hitakarun",
"url": "https://questionsmedicales.fr/author/Atitaya%20Hitakarun",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand."
}
},
{
"@type": "Person",
"name": "Ryosuke Morimoto",
"url": "https://questionsmedicales.fr/author/Ryosuke%20Morimoto",
"affiliation": {
"@type": "Organization",
"name": "Department of Health and Nutrition, Faculty of Human Life Science, Shikoku University, Tokushima 771-1192, Japan."
}
},
{
"@type": "Person",
"name": "Yuji Isegawa",
"url": "https://questionsmedicales.fr/author/Yuji%20Isegawa",
"affiliation": {
"@type": "Organization",
"name": "Department of Applied Biological Chemistry, Graduate School of Agriculture, Osaka Metropolitan University, Sakai, Osaka 599-8531, Japan."
}
},
{
"@type": "Person",
"name": "Janejira Jaratsittisin",
"url": "https://questionsmedicales.fr/author/Janejira%20Jaratsittisin",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Spinal muscular atrophy.",
"datePublished": "2022-08-04",
"url": "https://questionsmedicales.fr/article/35927425",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41572-022-00380-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Adult Spinal Muscular Atrophy].",
"datePublished": "2022-09-14",
"url": "https://questionsmedicales.fr/article/36103897",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-1801-3785"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nusinersen for adults with spinal muscular atrophy.",
"datePublished": "2023-03-01",
"url": "https://questionsmedicales.fr/article/36854931",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10072-023-06698-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "New treatments in spinal muscular atrophy.",
"datePublished": "2022-10-31",
"url": "https://questionsmedicales.fr/article/36316089",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/archdischild-2021-323605"
}
},
{
"@type": "ScholarlyArticle",
"name": "Progress in spinal muscular atrophy research.",
"datePublished": "2022-08-08",
"url": "https://questionsmedicales.fr/article/35942665",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/WCO.0000000000001102"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes microbiologiques",
"item": "https://questionsmedicales.fr/mesh/D008827"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes physiologiques viraux",
"item": "https://questionsmedicales.fr/mesh/D018406"
},
{
"@type": "ListItem",
"position": 4,
"name": "Réplication virale",
"item": "https://questionsmedicales.fr/mesh/D014779"
},
{
"@type": "ListItem",
"position": 5,
"name": "Activation virale",
"item": "https://questionsmedicales.fr/mesh/D014775"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Activation virale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Activation virale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Activation virale",
"description": "Comment diagnostiquer une activation virale ?\nQuels tests sont utilisés pour détecter les virus activés ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on détecter un virus inactif ?\nLes biopsies sont-elles utiles pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Muscular+Atrophy,+Spinal#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Activation virale",
"description": "Quels sont les symptômes d'une activation virale ?\nLes symptômes varient-ils selon le virus ?\nL'activation virale cause-t-elle des complications ?\nLes symptômes apparaissent-ils rapidement ?\nPeut-on avoir des symptômes sans activation virale ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Muscular+Atrophy,+Spinal#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Activation virale",
"description": "Comment prévenir l'activation virale ?\nLe lavage des mains aide-t-il à prévenir les infections ?\nLes masques protègent-ils contre les virus ?\nLes voyages augmentent-ils le risque d'activation virale ?\nLes comportements à risque augmentent-ils l'activation virale ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Muscular+Atrophy,+Spinal#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Activation virale",
"description": "Quels traitements existent pour l'activation virale ?\nLes antibiotiques sont-ils efficaces contre les virus ?\nLes vaccins aident-ils à prévenir l'activation virale ?\nComment les antiviraux agissent-ils ?\nLes traitements sont-ils les mêmes pour tous les virus ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Muscular+Atrophy,+Spinal#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Activation virale",
"description": "Quelles sont les complications possibles d'une activation virale ?\nL'activation virale peut-elle entraîner des maladies chroniques ?\nLes complications sont-elles prévisibles ?\nLes enfants sont-ils plus à risque de complications ?\nComment gérer les complications d'une activation virale ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Muscular+Atrophy,+Spinal#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Activation virale",
"description": "Quels sont les facteurs de risque d'activation virale ?\nL'âge influence-t-il le risque d'activation virale ?\nLes maladies chroniques augmentent-elles le risque ?\nLe mode de vie affecte-t-il le risque d'activation virale ?\nLe stress psychologique influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Muscular+Atrophy,+Spinal#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une activation virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des cultures virales peuvent confirmer l'activation."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les virus activés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR et les sérologies sont couramment utilisés pour détecter les virus."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques orientent souvent vers une activation virale."
}
},
{
"@type": "Question",
"name": "Peut-on détecter un virus inactif ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les tests ne détectent que les virus actifs ou en phase de réplication."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles utiles pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies peuvent aider à identifier des infections virales localisées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une activation virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, douleurs musculaires et éruptions cutanées sont fréquents."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le virus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut provoquer des symptômes spécifiques et variés."
}
},
{
"@type": "Question",
"name": "L'activation virale cause-t-elle des complications ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des complications graves comme des pneumonies ou des encéphalites."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent apparaître rapidement ou après une période d'incubation prolongée."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans activation virale ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, d'autres maladies peuvent provoquer des symptômes similaires sans activation virale."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'activation virale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination, l'hygiène et l'évitement des contacts sont essentiels."
}
},
{
"@type": "Question",
"name": "Le lavage des mains aide-t-il à prévenir les infections ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon lavage des mains réduit le risque de transmission virale."
}
},
{
"@type": "Question",
"name": "Les masques protègent-ils contre les virus ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les masques peuvent réduire la transmission des virus respiratoires."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'activation virale ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent exposer à de nouveaux virus et augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les comportements à risque augmentent-ils l'activation virale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des comportements comme le partage d'aiguilles augmentent le risque d'infection."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour l'activation virale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux, les immunomodulateurs et les soins de soutien sont utilisés."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les virus ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales."
}
},
{
"@type": "Question",
"name": "Les vaccins aident-ils à prévenir l'activation virale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins peuvent prévenir certaines infections virales et leur activation."
}
},
{
"@type": "Question",
"name": "Comment les antiviraux agissent-ils ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils inhibent la réplication virale, réduisant ainsi la charge virale dans l'organisme."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils les mêmes pour tous les virus ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque virus peut nécessiter un traitement spécifique adapté."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une activation virale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la pneumonie, l'encéphalite ou des infections secondaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "L'activation virale peut-elle entraîner des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections virales peuvent provoquer des maladies chroniques comme l'hépatite."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévisibles selon le virus et l'état de santé de l'hôte."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque de complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus vulnérables à certaines complications virales."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications d'une activation virale ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et des traitements appropriés sont essentiels pour gérer les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'activation virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunodépression, le stress et les voyages fréquents augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'activation virale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées et les jeunes enfants sont plus à risque."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète ou le VIH augmentent le risque d'activation virale."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il le risque d'activation virale ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque d'activation virale."
}
},
{
"@type": "Question",
"name": "Le stress psychologique influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affaiblir le système immunitaire et augmenter le risque d'infection."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 07/03/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand.
Publications dans "Activation virale" :
4 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Department of Health and Nutrition, Faculty of Human Life Science, Shikoku University, Tokushima 771-1192, Japan.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Department of Applied Biological Chemistry, Graduate School of Agriculture, Osaka Metropolitan University, Sakai, Osaka 599-8531, Japan.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency, Pathum Thani, 12120, Thailand.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Laboratory of Molecular RNA Virology and Antiviral Strategies, Department of Microbiology, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Singapore.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Laboratory of Molecular RNA Virology and Antiviral Strategies, Department of Microbiology, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Singapore; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore. Electronic address: miccjh@nus.edu.sg.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, S. Luigi Gonzaga Hospital, Orbassano Turin, Italy.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, S. Luigi Gonzaga Hospital, Orbassano Turin, Italy.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, S. Luigi Gonzaga Hospital, Orbassano Turin, Italy.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, S. Luigi Gonzaga Hospital, Orbassano Turin, Italy. Electronic address: david.lembo@unito.it.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Kingdom of Saudi Arabia.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Kingdom of Saudi Arabia.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Centre for Global Health Research, University of Edinburgh, Edinburgh, UK.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, Jiangsu Province, PR China; Institute of Comparative Medicine, Yangzhou University, Yangzhou, 225009, Jiangsu Province, PR China.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Animal Infectious Disease Laboratory, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, PR China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, 225009, Jiangsu Province, PR China.
Publications dans "Activation virale" :
Spinal muscular atrophy (SMA) is a neurodegenerative disorder caused by mutations in SMN1 (encoding survival motor neuron protein (SMN)). Reduced expression of SMN leads to loss of α-motor neurons, se...
5q spinal muscular atrophy (SMA) is an autosomal recessive motor neuron disease affecting 1: 11000 live births and ranging from intrauterine to early adult onset. The course of the disease is progress...
Nusinersen was effective in improving motor function and survival in infantile and childhood-onset spinal muscular atrophy (SMA), and the value of real-world experiences in adult SMA patients increase...
Thirty-two SMA patients treated with nusinersen were included in the study....
Median age at nusinersen initiation was 33.5 (20.0-60.0) years and 23 of SMA patients were male. Six (18.8%) patients had SMA type 2, and 26 (81.2%) had SMA type 3. Median follow-up period of patients...
Overall, 78% of patients have responded to treatment according to HFMSE or 6MWT. ALSFRS-R and 6MWT may be alternative tools to monitor nusinersen effect....
Spinal muscular atrophy (SMA) is a severe neurodegenerative condition due to recessive mutations in the...
The development of new therapies has brought spinal muscular atrophy (SMA) into the spotlight. However, this was preceded by a long journey - from the first clinical description to the discovery of th...
Since 2016, the antisense oligonucleotide nusinersen has been (FDA) approved for the treatment of SMA, followed by the gene replacement therapy onasemnogene abeparvovec-xioi in 2019 and the small-mole...
This review aims to summarize the major clinical and basic science achievements in the field of SMA....
The 5q-associated spinal muscular atrophy (SMA) is a hereditary motor neuron disease leading to progressive tetraplegia, often involving the bulbopharyngeal and respiratory muscle groups. The disease ...
This review article provides an update on the current treatment strategies for SMA in children and adults....
Onasemnogene abeparvovec (Zolgensma...
Spinal muscular atrophy (SMA) is a progressive disease of the lower motor neurons associated with recessive loss of the SMN1 gene, and which leads to worsening weakness and disability, and is fatal in...
Respiratory failure is a major cause of morbidity and mortality in patients with Spinal Muscular Atrophy (SMA). Lack of endurance, or "fatigability," is an important symptom of SMA. In addition to res...
The purpose of this study was to explore RMF in patients with SMA....
We assessed a Respiratory Endurance Test (RET) in 19 children (median age [years]: 11) and 36 adults (median age [years]: 34) with SMA types 2 and 3. Participants were instructed to breath against an ...
The probability of RMF during the RET increased by 59%-69% over 60 breaths with every 10% increase in inspiratory threshold load (%PImax). Fatigability response was characterized by a large variabilit...
Patients with SMA demonstrate a dose-dependent increase in RMF without severe increase in exercise-induced muscle weakness or perceived fatigue. Inspiratory muscle loading in patients with SMA seems f...
Spinal muscular atrophy (SMA) is an autosomal recessive condition affecting lower motor neurons causing progressive muscle atrophy. Anorexia nervosa (AN) is a psychiatric disorder characterised by int...
A 14-year-old female with SMA2 presented with 12 months of declining body weight to a nadir of 24.8 kg (BMI 11). This was initially attributed to medical complications including pneumonia and gastroen...
Low body weight, feeding issues, gastrointestinal dysmotility, and respiratory infections are common in SMA and diagnostic overshadowing can lead to delayed recognition of anorexia nervosa. Change to ...